Phase II study of bortezomib with cisplatin as first-line treatment of malignant pleural mesothelioma (MPM): EORTC 08052 - O'Brien,M; Gaafar,RM; Popat,S; Grossi,F; Price,A; Talbot,DC; Cufer,T; Ottensmeier,CHH; Danson,S; Pallis,AG; Hasan,B; Van,Meerbeeck JP; et al. (AMER SOC CLINICAL ONCOLOGY, 2012)